Thousands of men with prostate cancer will be offered a more targeted radiotherapy by the NHS which requires just five doses.

Prostate cancer is the most common cancer in men in the UK, with more than 55,000 men being diagnosed every year ...

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, talazoparib, which has been approved for NHS use. The once-daily pill, with its ...

Jeremy Clarkson’s bombshell cancer diagnosis has put a spotlight on prostate cancer, triggering a surge in awareness and men ...